BDSX
BDSX
NASDAQ · Health Care

Biodesix Inc

$14.21
-0.39 (-2.67%)
As of Mar 29, 10:44 PM ET ·
Financial Highlights (FY 2026)
Revenue
116.18M
Net Income
-46,294,168
Gross Margin
81.1%
Profit Margin
-39.9%
Rev Growth
+32.3%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 116.18M 87.81M 49.37M 47.38M
Gross Profit 94.23M 71.22M 16.44M 15.77M
Operating Income -36,596,232 -24,893,514 3.95M 3.19M
Net Income -46,294,168 -31,490,251 3.95M 3.51M
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Rev Growth +32.3% +32.3% +11.0% +13.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 45.75M 45.75M 13.54M 13.68M
Total Equity 26.22M 26.22M 42.24M 42.97M
D/E Ratio 1.75 1.75 0.32 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -29,357,373 -21,078,908 4.35M 3.95M
Free Cash Flow 1.71M 2.32M